SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,835.78 776.01
( 1.02%)

Global Indices

Nasdaq

51,969.87 237.22
(0.46%)

Dow Jones

7,434.30 5.00
(0.07%)

Hang Seng

64,889.11 277.96
(0.43%)

Nikkei 225

10,738.51 99.34
(0.93%)

Forex

USD-INR

96.67 0.19
(0.20%)

EUR-INR

110.18 0.12
(0.10%)

GBP-INR

129.04 -0.01
(0.00%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

54.22

13062.9

EPS(TTM)

Face Value()

Div & Yield %

23.03

0.6

Back

Healthcare Global Enterprises reports consolidated net loss of Rs 9.43 crore in the December 2025 quarter

Feb 06,2026

Net loss of Healthcare Global Enterprises reported to Rs 9.43 crore in the quarter ended December 2025 as against net profit of Rs 6.98 crore during the previous quarter ended December 2024. Sales rose 13.21% to Rs 631.18 crore in the quarter ended December 2025 as against Rs 557.55 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	631.18	557.55	13
OPM %	17.36	15.85	-
PBDT	67.25	53.22	26
PBT	6.60	-3.30	LP
NP	-9.43	6.98	PL

76,835.78 776.01 ( 1.02%)

51,969.87 237.22 (0.46%)

7,434.30 5.00 (0.07%)

64,889.11 277.96 (0.43%)

10,738.51 99.34 (0.93%)

96.67 0.19 (0.20%)

110.18 0.12 (0.10%)

129.04 -0.01 (0.00%)

0.59 0.00 (-0.04%)